secwatch.observer — SEC 8-K summary
======================================

Issuer:     STERIS plc (STE)
CIK:        0001757898
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-212159
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STERIS appoints Pierre Boulud to board; Richard Breeden to retire at 2026 AGM
-----------------------------------------------------------------------------

- Richard C. Breeden notified he will not stand for reelection at 2026 AGM; retirement not due to any disagreement.
- Board increased from 9 to 10 members; Pierre Boulud appointed director effective May 5, 2026.
- Boulud is CEO of bioMérieux (in vitro diagnostics); previously COO at bioMérieux and exec at Ipsen.
- Boulud receives prorated fee of $76,989 in restricted stock units for remainder of board term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/0001193125-26-212159-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757898/000119312526212159/d27562d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-212159

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer